Randomized, double-blind, single-dose, 3-arm parallel design comparative pharmacokinetic and safety Phase I study of BAT1706 versus EU-sourced Avastin (Registered Trademark) and US-sourced Avastin (Registered Trademark) administered in healthy subjects
Phase of Trial: Phase I
Latest Information Update: 30 Mar 2018
At a glance
- Drugs Bevacizumab (Primary)
- Indications Cancer
- Focus Pharmacokinetics
- Sponsors Bio-Thera Solutions
- 30 Mar 2018 According to a Bio-Thera Solutions media release, data will be presented at the 2018 American Association for Cancer Research ("AACR") Annual Meeting.
- 21 Jan 2017 Status changed from not yet recruiting to recruiting.
- 22 Jun 2016 New trial record